Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Regenxbio Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 17,163 shares of RGNX stock, worth $130,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,163

Previous 18,782 8.62%

Holding current value

$130,782

Previous $219,000 17.81%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$10.49 - $14.39 $16,983 - $23,297	-1,619 Reduced 8.62%	17,163 $180,000
Q2 2024 Aug 12, 2024	BUY	$11.51 - $21.53 $81,145 - $151,786	7,050 Added 60.09%	18,782 $219,000
Q1 2024 May 09, 2024	SELL	$12.17 - $24.61 $6,547 - $13,240	-538 Reduced 4.38%	11,732 $247,000
Q4 2023 Feb 08, 2024	SELL	$12.89 - $20.82 $29,247 - $47,240	-2,269 Reduced 15.61%	12,270 $220,000
Q3 2023 Nov 07, 2023	BUY	$16.46 - $19.99 $14,320 - $17,391	870 Added 6.36%	14,539 $239,000
Q2 2023 Aug 09, 2023	BUY	$17.23 - $21.71 $11,475 - $14,458	666 Added 5.12%	13,669 $273,000
Q1 2023 May 08, 2023	BUY	$18.08 - $24.55 $14,210 - $19,296	786 Added 6.43%	13,003 $245,000
Q4 2022 Feb 07, 2023	SELL	$20.4 - $24.73 $12,280 - $14,887	-602 Reduced 4.7%	12,217 $277,000
Q3 2022 Nov 01, 2022	BUY	$22.29 - $35.04 $4,814 - $7,568	216 Added 1.71%	12,819 $339,000
Q2 2022 Aug 04, 2022	BUY	$19.35 - $35.04 $52,496 - $95,063	2,713 Added 27.43%	12,603 $311,000
Q1 2022 May 09, 2022	BUY	$24.62 - $34.31 $13,097 - $18,252	532 Added 5.68%	9,890 $328,000
Q4 2021 Feb 07, 2022	BUY	$30.19 - $40.28 $19,170 - $25,577	635 Added 7.28%	9,358 $321,000
Q3 2021 Nov 04, 2021	BUY	$29.09 - $45.68 $6,428 - $10,095	221 Added 2.6%	8,723 $366,000
Q2 2021 Aug 06, 2021	SELL	$32.46 - $40.48 $54,208 - $67,601	-1,670 Reduced 16.42%	8,502 $330,000
Q1 2021 May 06, 2021	BUY	$33.61 - $49.95 $119,819 - $178,071	3,565 Added 53.96%	10,172 $347,000
Q4 2020 Feb 09, 2021	BUY	$26.52 - $49.35 $42,432 - $78,960	1,600 Added 31.96%	6,607 $300,000
Q3 2020 Nov 10, 2020	BUY	$27.01 - $40.26 $918 - $1,368	34 Added 0.68%	5,007 $138,000
Q2 2020 Aug 06, 2020	BUY	$27.75 - $43.44 $8,463 - $13,249	305 Added 6.53%	4,973 $183,000
Q1 2020 May 11, 2020	BUY	$21.5 - $54.2 $19,457 - $49,051	905 Added 24.05%	4,668 $151,000
Q4 2019 Feb 05, 2020	BUY	$34.54 - $44.87 $9,360 - $12,159	271 Added 7.76%	3,763 $147,000
Q3 2019 Nov 12, 2019	BUY	$31.84 - $50.88 $21,842 - $34,903	686 Added 24.45%	3,492 $124,000
Q2 2019 Aug 08, 2019	BUY	$42.0 - $59.29 $8,904 - $12,569	212 Added 8.17%	2,806 $144,000
Q1 2019 Apr 26, 2019	BUY	$40.82 - $62.45 $9,184 - $14,051	225 Added 9.5%	2,594 $149,000
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $13,258 - $25,475	-339 Reduced 12.52%	2,369 $97,000
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $176,020 - $222,462	2,708 New	2,708 $204,000

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Regenxbio Inc. Transaction History